Retrospective Clinical-Laboratory Data Analysis of Neuroborreliosis in Northern Rhineland-Palatinate/ Hessen

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037759

Enrollment

400

Registered

2025-09-22

Start date

2025-06-17

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A69.2

Interventions

Group 1: In this observational study CSF- and blood-sample constellations in patients with clinical manifestation of Neuroborrelioses were examined. Within the observation period of 01/2014-12/2024 al

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis with Neuroborrelioses

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The primary endpoint of this study is to detect specific constellations in CSF and blood samples for the various clinical presentations of Neuroborreliosis (i.e. erythema migrans, uni-/ bilateral facial palsy, (poly-)radiculitis, Bannwarth's syndrome, polyneuropathy, meningitis, encephalitis, myelitis, encephalomyelitis, vasculitis).	—

Secondary

Measure	Time frame
The secondary endpoint is the evaluation of the different clinical manifestations of Neuroborreliosis in terms of age, sex, history of tick bite and time to clinical manifestation and regional distribution pattern.	—

Countries

Germany

Contacts

Public ContactRalph Werner

Katholisches Klinikum Koblenz-Montabaur, Brüderhaus Koblenz, Klinik für Neurologie

r.werner@bbtgruppe.de+492614966445

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026